Consider susceptibility to the following pulmonary pathogens- 1. M. tuberculosis 2. P. aeruginosa 3. S. aureus 4. Nocardia sp. Which of the above is/are associated with long-term glucocoicoid therapy?
**Core Concept**
The question is testing the association between long-term glucocorticoid therapy and susceptibility to specific pulmonary pathogens. Glucocorticoids suppress the immune system, increasing the risk of infections, particularly those caused by opportunistic pathogens.
**Why the Correct Answer is Right**
Long-term glucocorticoid therapy impairs the function of neutrophils, macrophages, and other immune cells, making patients more susceptible to infections. Specifically, glucocorticoids decrease the production of pro-inflammatory cytokines, such as IL-12 and TNF-alpha, which are essential for controlling infections caused by intracellular pathogens like M. tuberculosis. Additionally, glucocorticoids increase the production of anti-inflammatory cytokines, such as IL-10, which can exacerbate infections caused by opportunistic pathogens like Nocardia.
* **Option A:** M. tuberculosis is not directly associated with glucocorticoid therapy, although it can be a risk factor in patients with underlying tuberculosis. Glucocorticoids can reactivate latent tuberculosis, but they do not increase susceptibility to M. tuberculosis in immunocompetent individuals.
* **Option B:** P. aeruginosa is a gram-negative bacterium that can cause opportunistic infections, but it is not specifically associated with glucocorticoid therapy. P. aeruginosa infections are more common in patients with cystic fibrosis, chronic lung disease, or immunocompromised states.
* **Option C:** Nocardia sp. is an opportunistic pathogen that can cause infections in immunocompromised patients, including those on long-term glucocorticoid therapy. Nocardia infections are characterized by the formation of abscesses and granulomas in the lungs and can be severe in patients with compromised immune function.
* **Option D:** S. aureus is a gram-positive bacterium that can cause skin and soft tissue infections, as well as respiratory tract infections. While S. aureus can cause opportunistic infections in immunocompromised patients, it is not specifically associated with glucocorticoid therapy.
**Clinical Pearl / High-Yield Fact**
Patients on long-term glucocorticoid therapy should be monitored for signs of infection, particularly those caused by opportunistic pathogens like Nocardia. These patients should also be screened for latent tuberculosis and receive prophylactic therapy to prevent reactivation.
**Correct Answer:** C. Nocardia sp.